Share
At a glance
- Treatment
- Procarbazine + lomustine (CCNU) + vincristine
- Used in selected settings
- Selected gliomas
- How it is given
- The treatment calendar below identifies the infusions, tablets or capsules used in this regimen.
- Before you start
- Save your 24-hour oncology number and have a thermometer and written medicine calendar available.
What this treatment is and how it works
PCV combines procarbazine, lomustine (CCNU) and vincristine for selected gliomas. Different recognised PCV calendars exist; the example below is one 6-week protocol and must not be blended with another. Using medicines with different actions helps attack cancer cells in more than one way. Healthy cells can also be affected, causing side effects.
When it may be used
PCV may be used for selected gliomas, which are tumours arising in the brain. It may be part of initial treatment, often with surgery and radiotherapy, or used when a tumour grows again. The aim is to control tumour growth and delay progression. The choice depends on the tumour type, its molecular test results, previous treatment and your health.
A listed use is not a claim that every brand is licensed for that use in every country. Your oncologist will explain why this treatment is appropriate for you.
Before treatment
Before starting, tell the team about previous cancer treatment, allergies, infection symptoms, heart, lung, kidney or liver disease, hearing or nerve problems, diabetes and all medicines you take. Discuss pregnancy, contraception and fertility. Ask for a written treatment calendar, supportive-medicine instructions and a 24-hour oncology contact number. Baseline blood tests usually include a full blood count and kidney and liver function; additional tests depend on the medicine and your health. Before chemotherapy that reaches the whole body, the team should check for current or past hepatitis B infection. If a test is positive, extra monitoring or antiviral treatment may be needed to prevent the virus becoming active again. The team will coordinate testing and treatment; do not delay urgent cancer treatment yourself.
How treatment is given and the schedule
| When | What happens |
|---|---|
| Day 1 in this example | Lomustine as a single prescribed oral dose. Do not take it daily. |
| Days 8–21 | Procarbazine capsules on the prescribed days. |
| Days 8 and 29 | Vincristine into a vein. |
| Cycle length in this example | 42 days (6 weeks), as used in an oligodendroglioma protocol. Other validated PCV plans use 56 days (8 weeks) or different treatment days. A repeat lomustine dose must not be taken early; blood-count recovery is checked first. |
Anti-sickness treatment and often a preventive constipation plan are provided. A pharmacist must review procarbazine interactions and give a written food and alcohol plan.
- Procarbazine is an oral chemotherapy medicine that damages DNA and has important food and medicine interactions.
- Lomustine (CCNU) is an oral nitrosourea chemotherapy medicine with delayed effects on blood counts.
The dose is calculated for your treatment and health. Rest periods, delays or dose changes may be needed. Do not change doses or treatment dates yourself, except to follow specific instructions to stop a medicine and seek help for warning symptoms. The team will give you a revised plan when needed.
During an infusion, tell the nurse immediately about pain, burning, swelling or leaking around the cannula or line. Do not massage the area or apply heat or ice unless the team instructs you.
Tests and monitoring during treatment
Blood counts are monitored through the cycle because lomustine can cause a delayed fall, often several weeks after the dose. Liver and kidney function, lung symptoms, constipation and neuropathy are reviewed.
At each review, describe symptoms since the previous dose, including problems that have already settled. Blood tests can detect effects before you feel them. Your team may delay, reduce, omit or stop a medicine if results or symptoms make this necessary. The decision depends on the exact protocol; a normal result does not make new symptoms safe to ignore.
Side effects: what to expect
Side-effect rates depend on the exact protocol, doses and other treatments. Frequencies from individual-drug labels cannot simply be added together or treated as regimen rates. The groups below describe the expected clinical pattern without assigning unsupported percentages.
You are unlikely to have all of these effects. This is not an exhaustive list. Tell the team about any new or troublesome symptom, including one not mentioned here.
Common or more frequent side effects
| Possible effect | What you can do | When to contact the team |
|---|---|---|
| Low blood counts | White cells fight infection, red cells carry oxygen and platelets help clotting. Treatment can lower one or more of these. Wash hands, avoid close contact with people who are unwell and keep blood-test appointments. | Call immediately for fever, shaking chills or feeling suddenly unwell. Report unusual bruising, bleeding, marked tiredness or increasing breathlessness. Do not wait for a blood-test result before seeking help. |
| Feeling or being sick | Take preventive anti-sickness medicines at the prescribed times. Try small meals and frequent small drinks; avoid strong food smells if they worsen nausea. | Contact the team the same day if medicines are not controlling symptoms. Seek urgent advice if you cannot keep fluids down, feel faint or pass much less urine. |
| Tiredness and reduced stamina | Balance rest with short periods of gentle activity. Prioritise tasks and accept help with shopping, meals or transport. Tell the team about poor sleep or pain. | Report fatigue that prevents basic activities or is worsening. Sudden breathlessness, chest pain, fainting or confusion needs urgent assessment. |
| Constipation | Keep a bowel record. Gentle movement, usual fluids and a prescribed laxative can help. Ask before using suppositories or enemas when blood counts may be low. | Contact the team for worsening constipation. A swollen or painful abdomen, vomiting or inability to pass wind needs urgent assessment; do not simply add laxatives. |
| Tingling, numbness or altered sensation | Protect hands and feet from burns and injury. Wear supportive footwear, check skin regularly and take care with balance. | Report symptoms before the next dose, especially if buttons, writing, walking or sleep are affected. New weakness, marked unsteadiness or difficulty breathing needs urgent assessment. |
| Reduced appetite or changes in eating | Try smaller, frequent meals with protein and energy-rich foods you tolerate. Ask for a dietitian if your weight or intake is falling. | Report ongoing weight loss or difficulty eating. Inability to drink or signs of dehydration needs same-day urgent advice. |
Other reported side effects (frequency varies)
These effects may be common in some treatment settings, less common in others, or have no reliable frequency estimate. Their position here does not mean they are necessarily less frequent or less serious.
Hair thinning, mouth soreness, rash and liver-test changes can occur. Delayed toxicity means the later weeks of a cycle still require vigilance.
Report these at review, or sooner if worsening. Use the urgent guidance for symptoms that affect breathing, drinking, urination, walking, consciousness or bleeding.
Important serious side effects, including rare effects
Serious does not always mean rare. Where reliable incidence is unavailable, no numerical frequency is assigned. The action to take matters even when the likelihood is uncertain.
Severe slowing of the bowel (ileus)
Constipation with abdominal swelling, significant pain, vomiting or inability to pass wind needs urgent assessment. Do not keep increasing fibre or laxatives while waiting.
Serious neurological symptoms
New confusion, marked weakness, trouble walking or speaking, a seizure or sudden vision change needs immediate medical assessment. These symptoms may have several causes and must not be attributed to chemotherapy without evaluation.
Inflammation or injury in the lungs
A new cough, breathlessness, chest discomfort or falling exercise tolerance needs urgent oncology contact. Severe or rapidly worsening breathing difficulty is an emergency. Infection and other causes must also be considered.
A later second cancer
Some chemotherapy medicines can increase the risk of another cancer, including a blood cancer, years later. This is considered when balancing treatment benefits and risks. Keep follow-up appointments and report persistent unexplained symptoms.
Serious infection or sepsis
Low white cells can allow an infection to become life-threatening quickly. Fever, shaking chills, rapid breathing, confusion or sudden deterioration needs immediate help. Infection is possible even with a normal temperature.
Practical advice for this treatment
Avoid alcohol during procarbazine and for the period advised before and after it. Obtain a specific list of foods high in tyramine to avoid, such as aged or fermented products. Check antidepressants, decongestants, cough medicines, sedatives and other medicines with the pharmacist before use. A sudden severe headache with palpitations or chest pain needs emergency assessment.
Taking cancer medicines at home
Keep cancer tablets or capsules in their labelled packaging, away from children and pets. Do not share them or put them in a household pill organiser unless the oncology pharmacist agrees. Do not crush, open, split or dissolve them without product-specific pharmacy instructions. A caregiver who handles the medicine should follow the pharmacy’s precautions. Return unused medicine to the pharmacy. If you miss a dose or vomit after one, do not take an extra dose; contact the team and follow the medicine-specific plan. If you accidentally take an extra dose or the wrong strength, contact the oncology team urgently even if you feel well. Do not try to make yourself vomit or work out a compensating dose yourself.
Medicines, interactions and vaccinations
Give the oncology pharmacist a complete list of prescription medicines, over-the-counter products, vitamins, herbal and Ayurvedic remedies and supplements. Ask before starting anything new. Do not stop prescribed medicines, including anticoagulants or infection-prevention medicines, without a coordinated plan. Live vaccines are generally unsuitable while immunity is suppressed; discuss vaccine type and timing with the team. Non-live vaccines may be offered, although protection can be reduced. Follow any specific stop-and-call instructions for the cancer medicine on this page or in your written treatment plan.
- Vincristine: Azole antifungals and some antibiotics or antivirals can greatly increase nerve toxicity. Strong pain medicines and other constipating drugs may worsen bowel problems.
Procarbazine needs a specific interaction review for antidepressants, MAO inhibitors, cough/cold medicines, sedatives, alcohol and tyramine-rich foods. Follow the oncology pharmacist’s written restrictions and timing. Do not stop an antidepressant abruptly yourself.
Pregnancy, fertility and breastfeeding
Chemotherapy can harm a developing baby and may affect fertility temporarily or permanently. Discuss sperm, egg or embryo storage before treatment when feasible. If you could become pregnant, or your partner could become pregnant, use effective contraception during treatment and for the drug-specific period afterwards. Ask for a written end date based on every medicine in your plan: the required period differs by product and can extend for months. Periods stopping does not guarantee infertility. Tell the team immediately about a suspected pregnancy. Do not breastfeed during treatment; restart only after the team confirms the interval for the exact medicine and formulation.
Everyday life
Gentle activity, regular meals and rest can help you cope. Prepare food hygienically and drink according to your individual fluid plan. Avoid smoking; ask whether alcohol is safe with your exact treatment and other medicines. Plan work, travel and driving around symptoms and monitoring visits. Do not drive if dizzy, sleepy, weak, visually affected or impaired by neuropathy. You can usually be close to family and friends: chemotherapy does not make you radioactive. Follow the unit’s instructions for handling urine, vomit, laundry and sexual precautions for the period it specifies.
When to contact the oncology team
Contact the oncology team the same day for persistent vomiting or diarrhoea, difficulty drinking, reduced urine, mouth pain affecting eating, new cough, jaundice, a painful or spreading rash, unusual bruising, worsening constipation or new nerve symptoms. Use the more urgent instructions for the particular symptom when given above. If the team cannot be reached and you are unwell, seek urgent medical care.
Write down your hospital’s daytime and out-of-hours numbers before treatment. CTI’s general contact details do not replace the emergency number provided by your treating hospital.
After treatment
Keep the planned blood tests and follow-up appointments after the last dose. Blood counts and immunity may take time to recover, and some effects can start or persist later. Contact the team about symptoms rather than waiting for a routine visit. Keep a treatment summary, including drug names, dates and any serious reactions, for future doctors. Response may be assessed with examination, scans or blood or marrow tests, depending on the cancer.
Words you may hear
- Glioma
- A group of tumours that start in supporting cells of the brain or spinal cord.
Frequently asked questions
Is lomustine taken every day with procarbazine?
No. In this example it is one dose on day 1 of a 6-week cycle. Taking it daily can cause a fatal overdose.
Why is my hospital’s PCV calendar different?
Other validated schedules use different days. Follow the single written protocol issued by your treating team.
Will I get every side effect listed?
No. Many people have only some of them. Your dose, other medicines, health and previous treatment all affect risk. Reporting symptoms early often makes them easier to manage.
Does having few side effects mean treatment is not working?
No. Side effects do not reliably show how well cancer treatment is working. The team assesses response using the appropriate tests.
Can a dose be reduced or delayed?
Yes. Blood counts, organ function or side effects may require a delay, reduction, omission or change. The team balances safety with the treatment aim; do not change doses yourself. Follow the specific instructions to stop a medicine and seek help if a warning symptom occurs.
Can I take vitamins, herbal or Ayurvedic products?
Check every product with the oncology pharmacist first. “Natural” does not mean interaction-free, and some products can affect the liver, bleeding or drug levels.
What should I have ready at home?
A thermometer, the 24-hour oncology number, a treatment calendar, your medicine list and prescribed symptom medicines. Arrange help with transport or meals if needed.
When should I call instead of waiting for the next appointment?
Use the urgent-help instructions on this page. Fever, sudden illness, uncontrolled symptoms or difficulty drinking should not wait until the next treatment visit.
Individual medicine guides
- Lomustine
- Vincristine
Sources and further reading
Summary of Product Characteristics
Product-specific details vary by formulation and treatment protocol.
Professional reference resources. These describe the specific product, warnings, interactions, monitoring and adverse effects. For US substitutes, the document is prescribing information rather than an SmPC. Check the product actually dispensed in India.
- Vincristine sulfate 1 mg/ml — Hospira UK. Accessed 16 October 2026. Current company-supplied/regulatory product information; not asserted to be the originator brand.
- Lomustine medac — manufacturer-hosted SmPC. Accessed 16 October 2026.
- Matulane (procarbazine) — current US prescribing information via DailyMed, revised October 2026. Accessed 16 October 2026. A current UK SmPC could not be retrieved; current manufacturer US prescribing information is an explicitly identified substitute.
Other authoritative references
- eviQ / Cancer Institute NSW — PCV. Accessed 16 October 2026.
- Cancer Research UK — alternative PCV calendar. Accessed 16 October 2026.
- NCI — infection and neutropenia. Accessed 16 October 2026.
- NCI — mouth and throat problems. Accessed 16 October 2026.
- NCI — diarrhoea. Accessed 16 October 2026.
- NCI — fatigue. Accessed 16 October 2026.
- BC Cancer — CNMODPCV Protocol. Accessed 16 October 2026. Independent cross-check: TREATMENT; TESTS; PRECAUTIONS; dose modifications / treatment schedule.
- eviQ oligodendroglioma PCV protocol. Accessed 16 October 2026. Independent cross-check: Treatment schedule: lomustine day 1; procarbazine days 8–21; vincristine days 8 and 29; 42-day cycle.
- NCCP HSE eight-week PCV protocol. Accessed 16 October 2026. Independent cross-check: Treatment schedule: 56-day cycle and same 1 / 8–21 / 8,29 day pattern.
- BC Cancer — Lomustine Monograph. Accessed 16 October 2026. Independent cross-check: USES; SPECIAL PRECAUTIONS; SIDE EFFECTS; INTERACTIONS; DOSAGE GUIDELINES.
- BC Cancer — Procarbazine Monograph. Accessed 16 October 2026. Independent cross-check: USES; SPECIAL PRECAUTIONS; SIDE EFFECTS; INTERACTIONS; DOSAGE GUIDELINES.
- ASCO hepatitis B screening and management opinion. Accessed 16 October 2026. Independent cross-check: Provisional Clinical Opinion: universal three-test screening before or at systemic anticancer therapy; chronic/past infection management.
Editorially approved by Dr (Prof) Vijay Agarwal
Professor and Lead Consultant – Medical Oncology
